Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study
Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, et al. (21 authors)
medRxiv · 2021-10
Abstract
ABSTRACT Concomitant treatment for chronic hepatitis C virus infection and multidrug-resistant tuberculosis is safe and effective.
MeSH terms
- Rifampicin
- Medicine
- Virology
- Tuberculosis
- Concomitant
- Chronic hepatitis
- Hepatitis a virus
- Virus